Universal mass vaccination against rotavirus: Indirect effects on rotavirus infections in neonates and unvaccinated young infants not eligible for vaccination

Journal of Infectious Diseases

Volumn 214, Issue 4, 2016, Pages 546-555

  Prelog, Martina ^a   Gorth, Peter ^a   Zwazl, Ines ^c   Kleines, Michael ^b,d   Streng, Andrea ^a   Zlamy, Manuela ^d   Heinz Erian, Peter ^d   Wiedermann, Ursula ^c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Infants; Neonates; Rotavirus; Vaccination

Indexed keywords

C REACTIVE PROTEIN; ROTAVIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; AUSTRIA; CHILD; COMMUNITY ACQUIRED INFECTION; CONTROLLED STUDY; DEHYDRATION; FEMALE; HOSPITAL INFECTION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFANT; LONG TERM CARE; LYMPHOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MASS IMMUNIZATION; NEWBORN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ROTAVIRUS INFECTION; SEASONAL VARIATION; THROMBOCYTE COUNT; UNIVERSAL PRECAUTION; EPIDEMIOLOGICAL MONITORING; IMMUNOLOGY; INCIDENCE; PRESCHOOL CHILD; PROCEDURES; ROTAVIRUS INFECTIONS;

ADOLESCENT; AUSTRIA; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGICAL MONITORING; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MASS VACCINATION; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES;

EID: 84988950290     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiw186     Document Type: Article

References (48)

1. Dennehy PH. Treatment and prevention of rotavirus infection in children. Curr Infect Dis Rep 2013; 15:242-50.
2. Glass RI, Parashar UD, Bresee JS, et al. Rotavirus vaccines: current prospects and future challenges. Lancet 2006; 368:323-32.
3. Rha B, Tate JE,Weintraub E, et al. Intussusception following rotavirus vaccination: an updated review of the available evidence. Expert Rev Vaccines 2014; 13:1339-48.
4. Uhlig U, Kostev K, Schuster V, Koletzko S, Uhlig HH. Impact of rotavirus vaccination in Germany: rotavirus surveillance, hospitalization, side effects and comparison of vaccines. Pediatr Infect Dis J 2014; 33:e299-304.
5. Atchison C, Collins S, Brown D, Ramsay ME, Ladhani S; PHE Rotavirus Surveillance Network. Reduction in rotavirus disease due to the infant immunisation programme in England: evidence from national surveillance. J Infect 2015; 71:128-31.
6. Karafillakis E, Hassounah S, Atchison C. Effectiveness and impact of rotavirus vaccines in Europe, 2006-2014. Vaccine 2015; 33:2097-107.
7. Huppertz H, Borte M, Schuster V, Giaquinto C, Vesikari T. Report of the Third European Expert Meeting on Rotavirus Vaccination: progress in rotavirus universal mass vaccination in Europe. Vaccine 2014; 32:4243-8.
8. Parez N, Giaquinto C, Du Roure C, et al. Rotavirus vaccination in Europe: drivers and barriers. Lancet Infect Dis 2014; 14:416-25.
9. Lantto M, Renko M, Uhari M. Changes in infectious disease mortality in children during the past three decades. Pediatr Infect Dis J 2013; 32:e355-9.
10. Clark A, Jit M, Andrews N, Atchison C, Edmunds WJ, Sanderson C. Evaluating the potential risks and benefits of infant rotavirus vaccination in England. Vaccine 2014; 32:3604-10.
11. Paulke-Korinek M, Kollaritsch H, Aberle SW, et al. Sustained low hospitalization rates after four years of rotavirus mass vaccination in Austria. Vaccine 2013; 31:2686-91.
12. Zlamy M, Kofler S, Orth D, et al. The impact of rotavirus mass vaccination on hospitalization rates, nosocomial rotavirus gastroenteritis and secondary blood stream infections. BMC Infect Dis 2013; 13:112.
13. Paulke-Korinek M, Kundi M, Rendi-Wagner P, et al. Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria. Vaccine 2011; 29:2791-6.
14. Lopman BA, Curns AT, Yen C, Parashar UD. Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. J Infect Dis 2011; 204:980-6.
15. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354:23-33.
16. Bruijning-Verhagen P, Mangen MJ, Felderhof M, et al. Targeted rotavirus vaccination of high-risk infants; a low cost and highly cost-effective alternative to universal vaccination. BMC Med 2013; 11:112.
17. Yeom JS, Kim YS, Kim RB, et al. Impact of rotavirus vaccine introduction on rotavirus-associated seizures and a related possible mechanism. J Child Neurol 2015; 30:729-34.
18. Rinder M, Tran AN, Bennet R, et al. Burden of severe rotavirus disease leading to hospitalization assessed in a prospective cohort study in Sweden. Scand J Infect Dis 2014; 46:294-302.
19. Curns AT, Steiner CA, Barrett M, et al. Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states. J Infect Dis 2010; 201:1617-24.
20. Paulke-Korinek M, Rendi-Wagner P, Kundi M, Kronik R, Kollaritsch H. Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in Austrian children. Pediatr Infect Dis J 2010; 29:319-23.
21. Rendi-Wagner P, Kundi M, Mikolasek A, et al. Active hospital-based surveillance of rotavirus diarrhea in Austrian children, period 1997 to 2003. Wien Klin Wochenschr 2006; 118:280-5.
22. Aslan A, Kurugol Z, Cetin H, Karakaslilar S, Koturoglu G. Comparison of Vesikari and Clark scales regarding the definition of severe rotavirus gastroenteritis in children. Infect Dis (Lond) 2015; 47:332-7.
23. Mäki M. A prospective clinical study of rotavirus diarrhea in young children. Acta Paediatr Scand 1981; 70:107-13.
24. Mast TC, Wang FT, Su S, Seeger JD. Evidence of herd immunity and sustained impact of rotavirus vaccination on the reduction of rotavirus-related medical encounters among infants from 2006 through 2011 in the United States. Ped Infect Dis J 2015; 34:615-20.
25. Weidemann F, Dehnert M, Koch J, Wichmann O, Höhle M. Modelling the epidemiological impact of rotavirus vaccination in Germany-a Bayesian approach. Vaccine 2014; 32:5250-7.
26. Roué JM, Nowak E, Le Gal G, et al. Impact of rotavirus vaccine on premature infants. Clin Vaccine Immunol 2014; 21:1404-9.
27. Cortese MM, Dahl RM, Curns AT, Parashar UD. Protection against gastroenteritis in US households with children who received rotavirus vaccine. J Infect Dis 2015; 211:558-62.
28. Dudareva-Vizule S, Koch J, An der Heiden M, Oberle D, Keller-Stanislawski B, Wichmann O. Impact of rotavirus vaccination in regions with low and moderate vaccine uptake in Germany. Hum Vaccin Immunother 2012; 8:1407-15.
29. Yen C, Jakob K, Esona MD, et al. Detection of fecal shedding of rotavirus vaccine in infants following their first dose of pentavalent rotavirus vaccine. Vaccine 2011; 29:4151-5.
30. Adlhoch C, Hoehne M, Littmann M, et al. Rotavirus vaccine effectiveness and case-control study on risk factors for breakthrough infections in Germany, 2010-2011. Pediatr Infect Dis J 2013; 32:e82-9.
31. Velázquez FR, Matson DO, Calva JJ, et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 1996; 335:1022-8.
32. Tate JE, Haynes A, Payne DC, et al. Trends in national rotavirus activity before and after introduction of rotavirus vaccine into the national immunization program in the United States, 2000 to 2012. Pediatr Infect Dis J 2013; 32:741-4.
33. Aliabadi N, Tate JE, Haynes AL, Parashar UD. Sustained decrease in laboratory detection of rotavirus after implementation of routine vaccination-United States, 2000-2014. MMWR Morb Mortal Wkly Rep 2015; 64:337-42.
34. Statistik Austria. Available at: www.statistik.at/web-de/statistiken/menschen- und-gesellschaft/bevoelkerung/geborene/index.html. Accessed 27 June 2015.
35. Armah GE, Kapikian AZ, Vesikari T, et al. Efficacy, immunogenicity, and safety of two doses of a tetravalent rotavirus vaccine RRV-TV in Ghana with the first dose administered during the neonatal period. J Infect Dis 2013; 208:423-31.
36. Chan J, Nirwati H, Triasih R, et al. Maternal antibodies to rotavirus: could they interfere with live rotavirus vaccines in developing countries? Vaccine 2011; 29:1242-7.
37. Asensi MT, Martinez-Costa C, Buesa J. Anti-rotavirus antibodies in human milk: quantification and neutralizing activity. J Pediatr Gastroenterol Nutr 2006; 42:560-7.
38. Rongsen-Chandola T, Strand TA, Goyal N, et al. Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in North Indian infants. Vaccine 2014; 32(suppl):A134-9.
39. Vesikari T, Karvonen A, Puustinen L, et al. Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants. Pediatr Infect Dis J 2004; 23:937-43.
40. Goveia MG, DiNubile MJ, Dallas MJ, et al. Efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine based on breastfeeding frequency. Pediatr Infect Dis J 2008; 27:656-8.
41. Bines JE, Danchin M, Jackson P, et al. Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomized, double-blind, placebo-controlled trial. Lancet Infect Dis 2015; 15:1389-97.
42. Candidate rotavirus vaccine recommendations for consideration by the WHO Strategic Advisory Group of Experts (SAGE) on Immunization. http://www. who.int/immunization/sage/2-Candidate-rota-recs-17-3-2009.pdf. Accessed 14 April 2016.
43. Korczoqski B, Szybist W. Serum procalcitonin and C-reactive protein in children with diarrhoea of various etologies. Acta Pediatr 2004; 93:169-73.
44. Wiegering V, Kaiser J, Tappe D, et al. Gastroenteritis in childhood: a retrospective study of 650 hospitalized pediatric patients. Int J Infect Dis 2011; 15:e401-7.
45. Chen SM, Lin CP, Tsai JD, Chao YH, Sheu JN. The significance of serum and fecal levels of interleukin-6 and interleukin-8 in hospitalized children with acute rotavirus and norovirus gastroenteritis. Pediatr Neonatol 2014; 55:120-6.
46. Tanju C, Ekrem G, Emel AB, Nur A. Mean platelet volume as a negative marker of inflammation in children with rotavirus gastroenteritis. Iran J Pediatr 2014; 24:617-22.
47. Hsu VP, Staat MA, Roberts N, et al. Use of active surveillance to validate International Classification of Diseases code estimates of rotavirus hospitalizations in children. Pediatrics 2005; 115:78-82.
48. Jayasinghe S, Macartney K. Estimating rotavirus gastroenteritis hospitalisations by using hospital episode statistics before and after the introduction of rotavirus vaccine in Australia. Vaccine 2013; 31:967-72.